The cost of treatment-related adverse events in metastatic breast cancer therapy: Taxanes versus capecitabine.
Ryan N Hansen
No relevant relationships to disclose
Melissa G. Brammer
Employment or Leadership Position - Genentech/Roche
Stock Ownership - Roche
Scott David Ramsey
Consultant or Advisory Role - Genentech
Deepa Lalla
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Sara A. Hurvitz
Consultant or Advisory Role - Genentech (U)
Sean D Sullivan
Research Funding - Genentech/Roche